Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

MLA

Brown, David M., et al. “Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.” Ophthalmology, vol. 122, no. 10, Oct. 2015, pp. 2044–52. EBSCOhost, https://doi.org/10.1016/j.ophtha.2015.06.017.

APA

Brown, D. M., Schmidt-Erfurth, U., Do, D. V., Holz, F. G., Boyer, D. S., Midena, E., Heier, J. S., Terasaki, H., Kaiser, P. K., Marcus, D. M., Nguyen, Q. D., Jaffe, G. J., Slakter, J. S., Simader, C., Soo, Y., Schmelter, T., Yancopoulos, G. D., Stahl, N., Vitti, R., & Berliner, A. J. (2015). Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. Ophthalmology, 122(10), 2044–2052. https://doi.org/10.1016/j.ophtha.2015.06.017

Chicago

Brown, David M., Ursula Schmidt-Erfurth, Diana V. Do, Frank G. Holz, David S. Boyer, Edoardo Midena, Jeffrey S. Heier, et al. 2015. “Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.” Ophthalmology 122 (10): 2044–52. doi:10.1016/j.ophtha.2015.06.017.